Summary
The relationship between insulin-like growth factor I (IGF I) and diabetic retinopathy was investigated. This somatomedin circulates bound to at least two large carrier proteins with molecular weights of approximately 150,000 and 35,000. Total and protein binding profiles of insulin-like growth factor I were determined in the serum of 18 patients who had had Type 1 (insulin-dependent) diabetes for 15–20 years, but had no signs of nephropathy and a similar degree of mild subclinical neuropathy. Nine had preproliferative or proliferative retinopathy and 9 had little or no background retinopathy but there was no difference in diabetes duration, insulin doses or glycaemic control between the two groups. In the latter group, the amounts of the somatomedin I and the serum profiles were similar to those in 9 healthy control subjects. In patients with advanced retinopathy, however, binding of insulin-like growth factor I to the carrier proteins was significantly altered. Binding to the low molecular weight protein increased to 140% whereas binding to the large molecular weight protein decreased to 70% of the normal level. In the latter Type 1 diabetic patients total serum insulin-like growth factor I was decreased to 60% of the normal level (p<0.02). When the alteration in serum profile was adjusted for, the level of somatomedin associated with the small carrier complex was normal whereas that associated with the large carrier complex was reduced by almost 60% in Type 1 diabetic patients with retinopathy. It is proposed that the total circulating somatomedin level is low in advanced diabetic retinopathy. Furthermore, changes in. the carrier binding of insulin-like growth factor I rather than in the total circulating level of the somatomedin may be involved in diabetic retinopathy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Merimée TJ, Zapf J, Froesch ER (1983) Insulin-like growth factors. Studies in diabetes with and without retinopathy. N Engl J Med 309: 527–530
Ashton JK, Dornan TL, Pocock AW, Turner RC, Bron AJ (1983) Plasma somatomedin activity and diabetic retinopathy. Clin Endocrinol 19: 105–110
Cohen MP, Jasty K, Rye DL (1977) Somatomedin in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 45: 236–239
Lamberton RP, Goodman AD, Kassoff A, Rubin CL, Treble DH, Saba TH, Merimée TJ, Dodds WJ (1984) Von Willebrand factor (VIII R: Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes 33: 125–129
Salardi S, Cacciari E, Ballardini D, Righetti F, Capelli N, Cicognani A, Zucchini S, Natali G, Tassinari D (1986) Relationships between growth factors (Somatomedin-C and growth hormones) and body development, metabolic control, and retinal changes in children and adolescents with IDDM. Diabetes 35: 832–836
Smith GL (1984) Somatomedin carrier proteins. Mol Cell Endocrinol 34: 83–89
Phillips LS, Vassilopoulou-Sellin R (1980) Somatomedins. N Engl J Med 302: 438–445
Grant M, Russell B, Fitzgerald C, Merimée TJ (1986) Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization. Diabetes 35: 416–420
Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick J, Kahn CR (1986) Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: 40-yr. follow-up study. Diabetes Care 9: 443–452
Sjöberg S, Gunnarsson R, Gjötterberg M, Lefvert AK, Persson A, Östman J (1987) Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 208–213
Thorell J, Johansson B (1971) Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta 25: 360–369
Hall K, Brandt J, Enberg G, Fryklund L (1979) Immunoreactive somatomedin A in human serum. J Clin Endocrinol Metab 48: 271–278
Furlanetto RW, Underwood LE, Van Wyk J, D'Ercole AJ (1977) Estimation of somatomedin C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60: 648–657
Daughaday WH, Mariz I, Blethen SL (1980) Inhibition of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J Clin Endocrinol Metab 51: 781–788
Hansson HA, Rozell B, Skottner A (1987) Rapid axoplasmic transport of insulin-like growth factor I in the sciatic nerve of adult rats. Cell Tissue Res 247: 241–247
Scatchard G (1949) The attractions of proteins for small molecules and ions. An NY Acad Sci 51: 660–672
Povoa G (1986) Somatomedin-binding protein. Isolation, determination, and studies of its regulation. Dissertation. Repro Print AB, Stockholm, pp 1–31
Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV (1984) Effect of diabetes and its control in insulin-like growth factors in the young subject with type I diabetes. Diabetes 33: 1175–1179
Tan K, Baxter RC (1986) Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age. J Clin Endocrinol Metab 63: 651–655
Baxter RC, Martin JL (1986) Radioimmonoassay of growth-hormone dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 504–512
Hall K, Hansson U, Lundin G, Luthman M, Persson B, Povoa G, Stangenberg M, Öfverholm U (1986) Serum levels of somatomedins and somatomedin — binding protein in pregnant women with type I or gestational diabetes and their infants. J Clin Endocrinol Metab 63: 1300–1306
Suikkari A, Koivisto VA, Rutanen EM, Yki-Järvinen H, Karonen SL, Seppälä M (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J Clin Endocrinol Metab 66: 266–272
Elgin RG, Busby Jr WH, Clemmons DR (1987) An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF I. Proc Natl Acad Sci USA 84: 3254–3258
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arner, P., Sjöberg, S., Gjötterberg, M. et al. Circulating insulin-like growth factor I in Type 1 (insulin-dependent) diabetic patients with retinopathy. Diabetologia 32, 753–758 (1989). https://doi.org/10.1007/BF00274537
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00274537